Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Conn BP"'
Autor:
Choi J; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Goulding SP; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Conn BP; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., McGann CD; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Dietze JL; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Kohler J; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Lenkala D; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Boudot A; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Rothenberg DA; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Turcott PJ; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Srouji JR; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Foley KC; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Rooney MS; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., van Buuren MM; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Gaynor RB; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Abelin JG; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Addona TA; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA., Juneja VR; BioNTech US Inc., 40 Erie Street, Suite 110, Cambridge, MA 02139, USA.
Publikováno v:
Cell reports methods [Cell Rep Methods] 2021 Sep 16; Vol. 1 (5), pp. 100084. Date of Electronic Publication: 2021 Sep 16 (Print Publication: 2021).
A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge.
Autor:
Madani N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. navid_madani@dfci.harvard.edu.; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02115, USA. navid_madani@dfci.harvard.edu.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, 02115, USA. navid_madani@dfci.harvard.edu., Princiotto AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Mach L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Ding S; Centre de Recherche du CHUM, Montreal, QC, H2X 0A9, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, QC, H2X 0A9, Canada., Prevost J; Centre de Recherche du CHUM, Montreal, QC, H2X 0A9, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, QC, H2X 0A9, Canada., Richard J; Centre de Recherche du CHUM, Montreal, QC, H2X 0A9, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, QC, H2X 0A9, Canada., Hora B; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Sutherland L; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Zhao CA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Conn BP; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Bradley T; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Moody MA; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Melillo B; Department of Chemistry, University of Pennsylvania, Philadelphia, PA, 19104, USA., Finzi A; Centre de Recherche du CHUM, Montreal, QC, H2X 0A9, Canada.; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, QC, H2X 0A9, Canada., Haynes BF; Department of Medicine, Department of Immunology, Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, 27710, USA., Smith Iii AB; Department of Chemistry, University of Pennsylvania, Philadelphia, PA, 19104, USA. smithab@sas.upenn.edu., Santra S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA., Sodroski J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. joseph_sodroski@dfci.harvard.edu.; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, 02115, USA. joseph_sodroski@dfci.harvard.edu.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. joseph_sodroski@dfci.harvard.edu.
Publikováno v:
Nature communications [Nat Commun] 2018 Jun 18; Vol. 9 (1), pp. 2363. Date of Electronic Publication: 2018 Jun 18.